Fibroblast activation protein ligand and use thereof
Patent Information
- Application Number
- HK62026127227
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-10-16
- Filing Date
- 2026-08-07
- Publication Date
- 2026-09-11
Smart Images

Figure 00000182_0000 
Figure 00000182_0001 
Figure 00000182_0002
Abstract
Description
(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480039386.9 (22) Application Date 2024.07.11 (66) Domestic Priority Data 202310843734.5 2023.07.11 CN 202311332360.7 2023.10.16 CN (85) PCT International Application Entering National Phase Date 2025.12.12 (86) PCT International Application Application Data PCT / CN2024 / 104918 2024.07.11 (87) PCT International Application Publication Data WO2025 / 011611 ZH 2025.01.16 (71) Applicant Jiangsu Hengrui Medicine Co., Ltd. Address 222047 No. 7 Kunlunshan Road, Economic and Technological Development Zone, Lianyungang City, Jiangsu Province Applicant: Tianjin Hengrui Pharmaceutical Co., Ltd. (72) Inventors: Ge Xinyue, Zhou Shunguang, Guo Feihu, Sun Jiyun, Li Zhongqing, Song Zihui, Zhang Mengyi (74) Patent Agency: Beijing Gecheng Intellectual Property Agency Co., Ltd. 11314 Patent Attorney: Cheng Wei (51) Int.Cl. C07K 7 / 08 (2006.01) C07K 14 / 81 (2006.01) C07K 7 / 06 (2006.01) A61K 38 / 08 (2019.01) (54) Invention Title: A Fibroblast Activating Protein Ligand and Its Use Thereof (57) Abstract: A fibroblast activating protein ligand and its use thereof, specifically relating to a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions containing the same, and its use in diagnosing or treating diseases involving fibroblast activating proteins such as tumors or cancer, CN 121532406 A 2026.02.13 CN 1 21 53 24 06 A
